サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1451473

感染監視ソリューション市場レポート：コンポーネント、展開タイプ、エンドユーザー、地域別、2024-2032

Infection Surveillance Solutions Market Report by Component (Software, Services), Deployment Type (On-premises, Cloud-based), End User (Hospitals, Clinics, Ambulatory Service Centers, Specialty Centers, and Others), and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 147 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
感染監視ソリューション市場レポート：コンポーネント、展開タイプ、エンドユーザー、地域別、2024-2032
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 147 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の感染監視ソリューション市場規模は、2023年に6億5,260万米ドルに達しました。今後、IMARC Groupでは、2024年から2032年にかけての成長率（CAGR）は7.65%で、2032年には13億1,480万米ドルに達すると予測しています。ヘルスケア関連感染（HAI）の増加、感染拡大防止のための厳格な規制遵守、患者データの自動取得を可能にするヘルスケアITの進歩などが、市場を推進している主な要因の一部です。

感染監視ソリューションは、ヘルスケア施設が患者集団内の感染症の流行、拡大、影響を監視・分析するために採用する包括的なシステムです。高度なデータ収集、統合、分析ツールを活用して、血流感染、手術部位感染、呼吸器感染など、さまざまなヘルスケア関連感染（HAI）を追跡し、報告します。このソリューションにより、ヘルスケアプロバイダーは潜在的なアウトブレイクを迅速に特定し、的を絞った介入策を実施し、最終的に患者の安全性を高めることができるため、感染監視ソリューションに対する需要は世界中で高まっています。

現在、感染制御を含む患者の安全性への関心が高まっていることが、市場の成長に寄与しています。これに伴い、ヘルスケアにおけるデータ主導の意思決定の重要性に対する意識の高まりが、市場の成長を強化しています。さらに、感染症にかかりやすい高齢者の間で感染監視ソリューションに対する需要が高まっていることも、市場にプラスの影響を与えています。さらに、感染症の発生を監視し緩和するための監視ソリューションへの投資が増加しており、業界の投資家に有利な成長機会を提供しています。さらに、データ分析、人工知能（AI）、機械学習（ML）の技術革新が感染監視ソリューションの機能を強化し、より効率的なものにしていることが市場の成長を支えています。このほか、世界各地のヘルスケアインフラ施設の改善が市場の成長を後押ししています。

感染監視ソリューション市場の動向と促進要因：

ヘルスケア関連感染（HAI）の増加

個人間のヘルスケア関連感染（HAI）の増加により、感染監視ソリューションの採用が増加していることが、市場の成長に寄与しています。これに伴い、これらの感染症は患者の健康を脅かし、入院期間の延長、医療費の増加、場合によっては死亡につながります。これとは別に、患者の安全性を高めるためにこれらの感染症を軽減する必要性が高まっています。患者データを継続的にモニタリング・分析することで、これらのソリューションは感染の早期発見を可能にし、ヘルスケア施設はタイムリーな介入を実施することができます。その結果、HAIが減少すれば、患者の転帰が改善されるだけでなく、ヘルスケア機関のコスト削減にもつながります。

感染拡大防止のための厳しい規制遵守

ヘルスケア業界では、規制要件や認定基準の遵守が不可欠です。メディケア・メディケイド・サービスセンター（CMS）や合同委員会（Joint Commission）などの規制機関は、医療関連感染（HAI）の報告と予防を義務付けています。また、コンプライアンスを怠ると、罰則や風評被害を受ける可能性があります。これに加えて、感染サーベイランス・ソリューションは、コンプライアンスを確保する上で重要な役割を果たします。感染率の正確なデータ収集、分析、報告を容易にし、ヘルスケア施設が規制上の要求を効率的に満たすのに役立ちます。さらに、認定機関は感染管理をヘルスケアの質の重要な要素として重視しています。さらに、ヘルスケア機関は、規制上のニーズを満たすだけでなく、認定を達成・維持し、評判と信頼性を高めることにも貢献する先進的な感染監視システムに投資しています。

ヘルスケアITの進歩

電子カルテ（EHR）、医療情報交換（HIE）、統合医療システムの導入が進んでいることが、市場の成長を後押ししています。これに伴い、感染監視ソリューションは既存のヘルスケアITインフラとシームレスにインターフェイスし、患者データ、検査結果、その他の関連情報を自動的に取り込むことができます。これらのシステムのインターフェイスは、監視プロセスを合理化し、分析のためのリアルタイムのデータの可用性を保証します。ヘルスケア専門家は、潜在的なアウトブレイクの早期発見と対応に役立つ実用的な洞察に素早くアクセスすることができます。さらに、これらのソリューションとヘルスケアITは、感染制御を強化するだけでなく、ヘルスケア提供の全体的な効率と有効性にも貢献します。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 感染監視ソリューションの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：コンポーネント別

  • ソフトウェア
    • 市場動向
    • 市場予測
  • サービス
    • 市場動向
    • 市場予測

第7章 市場内訳：展開タイプ別

  • オンプレミス
    • 市場動向
    • 市場予測
  • クラウド
    • 市場動向
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 診療所
    • 市場動向
    • 市場予測
  • 外来サービスセンター
    • 市場動向
    • 市場予測
  • 専門センター
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Baxter International Inc.
    • Becton Dickinson and Company
    • Centrak Inc.（Halma plc）
    • Cerner Corporation
    • CKM Healthcare Incorporated
    • Ecolab Inc.
    • International Business Machines Corporation
    • Medexter Healthcare
    • Perahealth Inc.
    • PointClickCare
    • Premier Inc.
    • Sunquest Information Systems Inc.（Roper Technologies Inc.）
図表

List of Figures

  • Figure 1: Global: Infection Surveillance Solutions Market: Major Drivers and Challenges
  • Figure 2: Global: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Infection Surveillance Solutions Market: Breakup by Component (in %), 2023
  • Figure 5: Global: Infection Surveillance Solutions Market: Breakup by Deployment Type (in %), 2023
  • Figure 6: Global: Infection Surveillance Solutions Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Infection Surveillance Solutions Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Infection Surveillance Solutions (Software) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Infection Surveillance Solutions (Software) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Infection Surveillance Solutions (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Infection Surveillance Solutions (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Infection Surveillance Solutions (On-premises) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Infection Surveillance Solutions (On-premises) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Infection Surveillance Solutions (Cloud-based) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Infection Surveillance Solutions (Cloud-based) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Infection Surveillance Solutions (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Infection Surveillance Solutions (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Infection Surveillance Solutions (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Infection Surveillance Solutions (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Infection Surveillance Solutions (Ambulatory Service Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Infection Surveillance Solutions (Ambulatory Service Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Infection Surveillance Solutions (Specialty Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Infection Surveillance Solutions (Specialty Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Infection Surveillance Solutions (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Infection Surveillance Solutions (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: North America: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: North America: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: United States: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: United States: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Canada: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Canada: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Asia-Pacific: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Asia-Pacific: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: China: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: China: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Japan: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Japan: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: India: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: India: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: South Korea: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: South Korea: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Australia: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Australia: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Indonesia: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Indonesia: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Others: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Others: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Europe: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Europe: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Germany: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Germany: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: France: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: France: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: United Kingdom: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: United Kingdom: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Italy: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Italy: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Spain: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Spain: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Russia: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Russia: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Others: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Others: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Latin America: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Latin America: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Brazil: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Brazil: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Mexico: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Mexico: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Middle East and Africa: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Middle East and Africa: Infection Surveillance Solutions Market: Breakup by Country (in %), 2023
  • Figure 74: Middle East and Africa: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Global: Infection Surveillance Solutions Industry: SWOT Analysis
  • Figure 76: Global: Infection Surveillance Solutions Industry: Value Chain Analysis
  • Figure 77: Global: Infection Surveillance Solutions Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Infection Surveillance Solutions Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Infection Surveillance Solutions Market Forecast: Breakup by Component (in Million US$), 2024-2032
  • Table 3: Global: Infection Surveillance Solutions Market Forecast: Breakup by Deployment Type (in Million US$), 2024-2032
  • Table 4: Global: Infection Surveillance Solutions Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Infection Surveillance Solutions Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Infection Surveillance Solutions Market: Competitive Structure
  • Table 7: Global: Infection Surveillance Solutions Market: Key Players
目次
Product Code: SR112024A4857

The global infection surveillance solutions market size reached US$ 652.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,314.8 Million by 2032, exhibiting a growth rate (CAGR) of 7.65% during 2024-2032. The growing healthcare-associated infections (HAIs), stringent regulatory compliance for preventing the spread of infection, and advancements in healthcare IT that allow for the automatic capture of patient data are some of the major factors propelling the market.

Infection surveillance solutions are comprehensive systems that are employed by healthcare facilities to monitor and analyze the prevalence, spread, and impact of infections within their patient populations. They utilize advanced data collection, integration, and analysis tools to track and report on various healthcare-associated infections (HAIs), such as bloodstream infections, surgical site infections, and respiratory infections. As they enable healthcare providers to promptly identify potential outbreaks, implement targeted interventions, and ultimately enhance patient safety, the demand for infection surveillance solutions is increasing worldwide.

At present, the rising focus on patient safety, which includes infection control, is contributing to the growth of the market. In line with this, the increasing awareness about the importance of data-driven decision-making in healthcare is strengthening the growth of the market. Moreover, the growing demand for infection surveillance solutions among the geriatric population, as they are more vulnerable to infections, is positively influencing the market. In addition, rising investments in surveillance solutions to monitor and mitigate infectious disease outbreaks is offering lucrative growth opportunities to industry investors. Furthermore, innovations in data analytics, artificial intelligence (AI), and machine learning (ML) are enhancing the capabilities of infection surveillance solutions and making them more efficient is supporting the growth of the market. Besides this, the improving healthcare infrastructure facilities across the globe is bolstering the growth of the market.

Infection Surveillance Solutions Market Trends/Drivers:

Rising healthcare-associated infections (HAIs)

The rising adoption of infection surveillance solutions due to the increasing healthcare-associated Infections (HAIs) among individuals is contributing to the growth of the market. In line with this, these infections cause threats to patient well-being that lead to extended hospital stays, increased healthcare costs, and, in some cases, mortality. Apart from this, there is a rise in the need to mitigate these infections to enhance patient safety. By continuously monitoring and analyzing patient data, these solutions enable early detection of infections and allow healthcare facilities to implement timely interventions. Consequently, the reduction in HAIs not only improves patient outcomes but also leads to cost savings for healthcare organizations.

Stringent regulatory compliance for preventing spread of infection

In the healthcare industry, compliance with regulatory requirements and accreditation standards is vital. Regulatory bodies, such as the Centers for Medicare and Medicaid Services (CMS) and the Joint Commission are mandating the reporting and prevention of healthcare-associated infections (HAIs). In addition, failure to comply can result in penalties and reputational damage. Besides this, infection surveillance solutions are instrumental in ensuring compliance. They facilitate accurate data collection, analysis, and reporting of infection rates, helping healthcare facilities meet regulatory demands efficiently. Additionally, accreditation bodies focus on infection control as a critical component of healthcare quality. Furthermore, healthcare organizations are investing in advanced infection surveillance systems that not only satisfy regulatory needs but also contribute to achieving and maintaining accreditation, enhancing their reputation and trustworthiness.

Advancements in healthcare IT

The increasing adoption of electronic health records (EHRs), health information exchange (HIE), and integrated health systems is bolstering the growth of the market. In line with this, infection surveillance solutions can seamlessly interface with existing healthcare IT infrastructure and allow for the automatic capture of patient data, laboratory results, and other pertinent information. The interface of these systems streamlines the surveillance process and ensures the availability of real-time data for analysis, which is offering a positive market outlook. Healthcare professionals can access actionable insights quickly that aid in early detection and response to potential outbreaks. Moreover, these solutions and healthcare IT not only enhance infection control but also contribute to the overall efficiency and effectiveness of healthcare delivery.

Infection Surveillance Solutions Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on component, deployment type, and end user.

Breakup by Component:

Software

Services

Software represents the largest market segment

The report has provided a detailed breakup and analysis of the market based on the component. This includes software and services. According to the report, software represented the largest segment. The software is responsible for the collection, integration, analysis, and presentation of data related to healthcare-associated infections (HAIs) and infectious diseases. It plays a vital role in transforming raw patient data into actionable insights for healthcare providers. It comprises numerous functionalities, such as data integration, real-time monitoring, data analysis, reporting and visualization, and compliance and regulatory support. In line with this, the software enables healthcare organizations to proactively manage infections, improve patient safety, and enhance overall healthcare quality, which is contributing to the growth of the market.

Breakup by Deployment Type:

On-premises

Cloud-based

On-premises accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the deployment type. This includes on-premises and cloud-based. According to the report, on-premises represented the largest segment. On-premises refers to the installation and operation of infection surveillance solutions within the physical infrastructure of a healthcare facility or organization. In this deployment model, all software, hardware, and data storage are maintained locally on-site. On-premises solutions can be customized to meet the specific needs and workflows of the organization and allow for tailored infection surveillance processes. Apart from this, it offers low-latency access to information that allows for real-time monitoring and response to infection trends. Organizations often choose this deployment model when they prioritize data control, security, and compliance while accepting the responsibility of managing their IT infrastructure.

Breakup by End User:

Hospitals

Clinics

Ambulatory Service Centers

Specialty Centers

Others

Hospitals hold the biggest market share

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, clinics, ambulatory service centers, specialty centers, and others. According to the report, hospitals represented the largest segment. Hospitals are characterized by their high patient volumes, complex care environments, and the critical need for infection control. Moreover, hospitals prioritize patient safety, and infection surveillance is fundamental in achieving this goal. These solutions enable hospitals to monitor, detect, and prevent healthcare-associated infections (HAIs) promptly, thereby reducing patient morbidity and mortality. In addition, efficient infection control helps hospitals optimize resource allocation. By identifying infection trends and risk factors, hospitals can allocate resources effectively and ensure that critical care units and staff are available where needed most.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest infection surveillance solutions market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share due to the presence of advanced healthcare infrastructure. Apart from this, the rising focus on healthcare quality and patient safety is contributing to the growth of the market in the region. In line with this, stringent regulatory requirements in North America are necessitating the implementation of comprehensive infection surveillance solutions, which is propelling the growth of the market. Besides this, the rising demand for solutions that have real-time data and analytics capabilities is bolstering the growth of the market in the North America region.

Competitive Landscape:

Key manufacturers are continuously investing in research and development (R&D) activities to enhance the capabilities of their software and hardware. This includes developing advanced analytics, machine learning (ML) algorithms, and predictive modeling to improve infection detection and prevention. In addition, companies are working closely with healthcare facilities to customize their solutions and seamlessly integrate them into existing healthcare IT ecosystems. This ensures that the solutions align with the specific needs and workflows of each organization. Apart from this, solution providers are enhancing their data encryption, access controls, and compliance features to meet stringent healthcare regulations due to the increasing focus on data security and privacy. Furthermore, major players are offering cloud-based solutions to provide scalability, flexibility, and easier access to real-time data.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Baxter International Inc.

Becton Dickinson and Company

Centrak Inc. (Halma plc)

Cerner Corporation

CKM Healthcare Incorporated

Ecolab Inc.

International Business Machines Corporation

Medexter Healthcare

Perahealth Inc.

PointClickCare

Premier Inc.

Sunquest Information Systems Inc. (Roper Technologies Inc.)

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Recent Developments:

In January 2022, BD (Becton, Dickinson and Company), a leading global medical technology company, collaborated with Pfizer Inc. and global charitable foundation Wellcome to better understand the role of diagnostics in advancing antimicrobial stewardship practices around the world.

In 2021, Ecolab, the global leader in water, hygiene and infection prevention solutions and services, launched its Hand Hygiene Compliance Measurement (HHCM) System, a digitally connected technology to systematically monitor and improve hand hygiene in healthcare settings, across Europe.

In June 2022, Premier, Inc. announced that it is extending its technological capabilities to long-term care (LTC) facilities and providing the same level of clinical surveillance used in the acute setting.

Key Questions Answered in This Report

  • 1. What was the size of the global infection surveillance solutions market in 2023?
  • 2. What is the expected growth rate of the global infection surveillance solutions market during 2024-2032?
  • 3. What are the key factors driving the global infection surveillance solutions market?
  • 4. What has been the impact of COVID-19 on the global infection surveillance solutions market?
  • 5. What is the breakup of the global infection surveillance solutions market based on the component?
  • 6. What is the breakup of the global infection surveillance solutions market based on the deployment type?
  • 7. What is the breakup of the global infection surveillance solutions market based on the end user?
  • 8. What are the key regions in the global infection surveillance solutions market?
  • 9. Who are the key players/companies in the global infection surveillance solutions market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Infection Surveillance Solutions Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Software
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Deployment Type

  • 7.1 On-premises
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cloud-based
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ambulatory Service Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Specialty Centers
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Baxter International Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Centrak Inc. (Halma plc)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Cerner Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 CKM Healthcare Incorporated
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Ecolab Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 International Business Machines Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Medexter Healthcare
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Perahealth Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 PointClickCare
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Premier Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Sunquest Information Systems Inc. (Roper Technologies Inc.)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 SWOT Analysis